NFKB1 and prostate carcinoma: Studies in prostate cancer have demonstrated that the inflammatory NF-κB signaling pathway is constitutively activated, primarily by TNF, and it aids in resistance to apoptosis by inducing expression of anti-apoptotic proteins such as Bcl-xL [117].